Zacks Small Cap Research on MSN1d
MGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System.
MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that ...
Creative Medical secures FDA clearance for dose escalation in Phase 1/2 trial
Creative Medical Technology Holdings announced that the U.S. Food and Drug Administration has cleared an expanded dose escalation for its ongoing Phase 1/2 trial of StemSpine usin ...
pharmaphorum2d
FDA clears Ionis drug as first therapy for rare disease FCS
Ionis Pharma's olezarsen has become the first FDA-approved drug therapy for adults ... The drug – formerly known as IONIS-APOCIII-LRx – has been cleared under the Tryngolza brand name as ...
MedTech Dive3d
Monogram robot wins FDA OK; Vicarious hit by supplier woes
Monogram Technologies secured 510(k) clearance for its robotic knee replacement system, while Vicarious Surgical blamed ...
FDA Clears Magstim Transcranial Magnetic Stimulation System for U.S. Adolescent Patient Treatment
This FDA clearance for the Magstim Horizon 3.0 and Inspire systems builds on the existing patient TMS clearances for adult patients, making it possible for physicians and nurse practitioners to treat ...
Sky Sports14d
PGA Tour: Wyndham Clark cleared of wrongdoing after free drop confusion at Arnold Palmer Invitational
The PGA Tour has cleared Wyndham Clark of a rules violation after the former US Open champion took a free drop during the second round of the Arnold Palmer Invitational at Bay Hill. Clark ...
Food Safety News14d
FDA increases import controls on some seafood and canned foods
The agency updates and modifies the alerts as needed. Recent modifications to FDA’s import alerts, as posted by the agency, are listed below. Click here to go to the FDA page with links to ...
Yahoo Finance15d
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B
The US Food and Drug Administration (FDA) has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding the company’s syndromic testing offerings in the US.
Targeted Oncology15d
FDA Clears Phase 1 Trial of MRANK-106 in Advanced Solid Tumors
The FDA cleared the investigational new drug application for MRANK-106, a dual WEE1/YES1 kinase inhibitor, targeting advanced solid tumors. The FDA has cleared the investigational new drug (IND) ...
Medical Device Network15d
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B
The latest authorised panel targets bacterial infections, including Campylobacter, Shigella, Yersinia enterocolitica, and Salmonella. Credit: © Qiagen. The US Food ...
MassDevice15d
FDA clears revision knee implant from Zimmer Biomet
The Persona Knee system. [Image courtesy of Zimmer Biomet] Zimmer Biomet (NYSE: ZBH) + announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur. The revision ...